{"id":"https://openalex.org/W2129404229","doi":"https://doi.org/10.1093/jnci/90.21.1648","title":"Macrophage Role in the Anti-Prostate Cancer Response to One Class of Antiangiogenic Agents","display_name":"Macrophage Role in the Anti-Prostate Cancer Response to One Class of Antiangiogenic Agents","alternate_titles":[],"publication_year":1998,"publication_date":"1998-11-04","ids":{"openalex":"https://openalex.org/W2129404229","doi":"https://doi.org/10.1093/jnci/90.21.1648","mag":"2129404229","pmid":"https://pubmed.ncbi.nlm.nih.gov/9811314"},"language":"en","primary_location":{"id":"doi:10.1093/jnci/90.21.1648","doi":"https://doi.org/10.1093/jnci/90.21.1648","is_oa":false,"landing_page_url":"https://doi.org/10.1093/jnci/90.21.1648","pdf_url":null,"source":{"id":"https://openalex.org/S98010888","display_name":"JNCI Journal of the National Cancer Institute","issn_l":"0027-8874","issn":["0027-8874","1460-2105"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JNCI Journal of the National Cancer Institute","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2129404229"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5067816762","display_name":"Ingrid B.J. Joseph","orcid":"https://orcid.org/0009-0009-7348-9138","observed_orcids":["https://orcid.org/0009-0009-7348-9138"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2799853436","display_name":"Johns Hopkins Medicine","ror":"https://ror.org/037zgn354","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799853436"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"I. B. J. K. Joseph","raw_affiliation_strings":["The Johns Hopkins Oncology Center, The Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Johns Hopkins Oncology Center, The Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2799853436"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5043265453","display_name":"John T. Isaacs","orcid":"https://orcid.org/0000-0002-3854-4658","observed_orcids":["https://orcid.org/0000-0002-3854-4658"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2799853436","display_name":"Johns Hopkins Medicine","ror":"https://ror.org/037zgn354","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799853436"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J. T. Isaacs","raw_affiliation_strings":["The Johns Hopkins Oncology Center, Department of Urology, The Johns Hopkins University School of Medicine, Baltimore, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Johns Hopkins Oncology Center, Department of Urology, The Johns Hopkins University School of Medicine, Baltimore, MD","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2799853436"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5067816762"],"corresponding_institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2799853436"],"apc_list":{"value":5436,"currency":"USD","value_usd":5436},"apc_paid":null,"fwci":3.1654,"has_fulltext":false,"cited_by_count":124,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.92638484,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"90","issue":"21","first_page":"1648","last_page":"1653"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11313","display_name":"Immune cells in cancer","score":0.9740999937057495,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11313","display_name":"Immune cells in cancer","score":0.9740999937057495,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.025100000202655792,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12626","display_name":"Cancer, Stress, Anesthesia, and Immune Response","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tumor-associated-macrophages","display_name":"tumor-associated macrophages","score":0.9860000014305115},{"id":"https://openalex.org/keywords/prostate-cancer","display_name":"prostate cancer","score":0.9399999976158142},{"id":"https://openalex.org/keywords/angiogenesis-inhibitors","display_name":"angiogenesis inhibitors","score":0.9440000057220459},{"id":"https://openalex.org/keywords/linomide","display_name":"linomide","score":0.7950000166893005},{"id":"https://openalex.org/keywords/thalidomide","display_name":"thalidomide","score":0.8859999775886536},{"id":"https://openalex.org/keywords/pentoxifylline","display_name":"pentoxifylline","score":1.0},{"id":"https://openalex.org/keywords/genistein","display_name":"genistein","score":1.0},{"id":"https://openalex.org/keywords/tnf-alpha","display_name":"TNF-\u03b1","score":0.9169999957084656},{"id":"https://openalex.org/keywords/gm-csf","display_name":"GM-CSF","score":0.9990000128746033},{"id":"https://openalex.org/keywords/plasminogen-activator-inhibitor-2","display_name":"plasminogen activator inhibitor-2","score":0.9950000047683716},{"id":"https://openalex.org/keywords/tumor-angiogenesis","display_name":"tumor angiogenesis","score":0.9710000157356262},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.6480000019073486}],"concepts":[{"id":"https://openalex.org/C2780404050","wikidata":"https://www.wikidata.org/wiki/Q416331","display_name":"Pentoxifylline","level":2,"score":0.71091628074646},{"id":"https://openalex.org/C2780394083","wikidata":"https://www.wikidata.org/wiki/Q539568","display_name":"Angiogenesis","level":2,"score":0.6075096726417542},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.6033152937889099},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5663663744926453},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.5148905515670776},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5074917674064636},{"id":"https://openalex.org/C2779609412","wikidata":"https://www.wikidata.org/wiki/Q203174","display_name":"Thalidomide","level":3,"score":0.4932820200920105},{"id":"https://openalex.org/C2777847059","wikidata":"https://www.wikidata.org/wiki/Q6537255","display_name":"Lewis lung carcinoma","level":4,"score":0.476855605840683},{"id":"https://openalex.org/C2779244956","wikidata":"https://www.wikidata.org/wiki/Q184204","display_name":"Macrophage","level":3,"score":0.45217186212539673},{"id":"https://openalex.org/C2779679481","wikidata":"https://www.wikidata.org/wiki/Q13581432","display_name":"Plasminogen activator","level":2,"score":0.4488822817802429},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.44089025259017944},{"id":"https://openalex.org/C2778298627","wikidata":"https://www.wikidata.org/wiki/Q415957","display_name":"Genistein","level":2,"score":0.44020557403564453},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.43607857823371887},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4075438678264618},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4013413190841675},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3985806405544281},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.32805734872817993},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.29895448684692383},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2180391550064087},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.07499387860298157},{"id":"https://openalex.org/C2779013556","wikidata":"https://www.wikidata.org/wiki/Q181876","display_name":"Metastasis","level":3,"score":0.06583130359649658},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004797","descriptor_name":"Enzyme-Linked Immunosorbent Assay","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006912","descriptor_name":"Hydroxyquinolines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D008264","descriptor_name":"Macrophages","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D008264","descriptor_name":"Macrophages","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009389","descriptor_name":"Neovascularization, Pathologic","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D009389","descriptor_name":"Neovascularization, Pathologic","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D010431","descriptor_name":"Pentoxifylline","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true},{"descriptor_ui":"D013792","descriptor_name":"Thalidomide","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014409","descriptor_name":"Tumor Necrosis Factor-alpha","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D014409","descriptor_name":"Tumor Necrosis Factor-alpha","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D016178","descriptor_name":"Granulocyte-Macrophage Colony-Stimulating Factor","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D016178","descriptor_name":"Granulocyte-Macrophage Colony-Stimulating Factor","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D019833","descriptor_name":"Genistein","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1093/jnci/90.21.1648","doi":"https://doi.org/10.1093/jnci/90.21.1648","is_oa":false,"landing_page_url":"https://doi.org/10.1093/jnci/90.21.1648","pdf_url":null,"source":{"id":"https://openalex.org/S98010888","display_name":"JNCI Journal of the National Cancer Institute","issn_l":"0027-8874","issn":["0027-8874","1460-2105"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JNCI Journal of the National Cancer Institute","raw_type":"journal-article"},{"id":"pmid:9811314","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9811314","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the National Cancer Institute","raw_type":"Comparative Study"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.325.6469","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.325.6469","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://jnci.oxfordjournals.org/content/90/21/1648.full.pdf","raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G8734158821","display_name":"LINOMIDE IN THE CHEMOPREVENTION OF PROSTATIC CANCER","funder_award_id":"R01CA062482","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":39,"referenced_works":["https://openalex.org/W1485139415","https://openalex.org/W1505736789","https://openalex.org/W1507160997","https://openalex.org/W1552838483","https://openalex.org/W1569333935","https://openalex.org/W1590842919","https://openalex.org/W1732719761","https://openalex.org/W1861459149","https://openalex.org/W1971538947","https://openalex.org/W1985147506","https://openalex.org/W1985804036","https://openalex.org/W1991148746","https://openalex.org/W2000000541","https://openalex.org/W2018803923","https://openalex.org/W2021780953","https://openalex.org/W2029837224","https://openalex.org/W2053740330","https://openalex.org/W2057218203","https://openalex.org/W2058629447","https://openalex.org/W2064840635","https://openalex.org/W2074342877","https://openalex.org/W2086359428","https://openalex.org/W2088743274","https://openalex.org/W2094466319","https://openalex.org/W2100607781","https://openalex.org/W2100918981","https://openalex.org/W2103342866","https://openalex.org/W2116910132","https://openalex.org/W2132156072","https://openalex.org/W2134582008","https://openalex.org/W2135519239","https://openalex.org/W2159133324","https://openalex.org/W2159746652","https://openalex.org/W2162777433","https://openalex.org/W2164772824","https://openalex.org/W2311972351","https://openalex.org/W2336139162","https://openalex.org/W2402784056","https://openalex.org/W2412803578"],"related_works":["https://openalex.org/W2103342866","https://openalex.org/W2074342877","https://openalex.org/W2375738602","https://openalex.org/W1565999352","https://openalex.org/W2053740330","https://openalex.org/W2164772824","https://openalex.org/W2132156072","https://openalex.org/W1962094436","https://openalex.org/W2125505483","https://openalex.org/W1995100059"],"abstract_inverted_index":{"BACKGROUND:":[0],"Tumor-associated":[1],"macrophages":[2,94],"(TAMs)":[3],"can":[4],"either":[5],"promote":[6],"angiogenesis":[7,25,262],"(i.e.,":[8],"the":[9,38,53,72,156,183,205,218,235,247,255],"formation":[10],"of":[11,37,57,66,74,107,135,144,148,158,169,182,204,230,234,258],"new":[12],"blood":[13,125,209,224],"vessels)":[14],"in":[15,33,51,86,99,112,128,223,251],"tumors":[16],"by":[17,26,88,101,133,171,190,193,196,200],"secreting":[18],"tumor":[19,208,213,231,261],"necrosis":[20],"factor-alpha":[21],"(TNF-alpha)":[22],"or":[23,50,165],"inhibit":[24],"producing":[27],"granulocyte-macrophage":[28],"colony-stimulating":[29],"factor":[30],"(GM-CSF),":[31],"which":[32],"turn":[34],"stimulates":[35],"production":[36,85,98,157,168],"antiangiogenic":[39,248,266],"protein":[40],"plasminogen":[41],"activator":[42],"inhibitor":[43],"type":[44],"2":[45],"(PAI-2).":[46],"We":[47],"tested,":[48,250],"alone":[49],"combination,":[52],"anti-prostate":[54],"cancer":[55],"activity":[56],"agents":[58,109,185,206,237,249],"that":[59,252],"perturb":[60],"macrophage":[61,142],"function.":[62],"METHODS:":[63],"By":[64],"use":[65,134],"enzyme-linked":[67],"immunosorbent":[68],"assays,":[69],"we":[70],"measured":[71],"effects":[73,106,257],"Linomide":[75,138,216,243],"(roquinimex),":[76],"thalidomide,":[77,151,192],"pentoxifylline,":[78,152,166,195],"and":[79,83,95,124,153,198,212,227,268],"genistein":[80,154],"on":[81,96,114,260],"TNF-alpha":[82,145],"GM-CSF":[84],"vitro":[87,100],"virally":[89],"transformed":[90],"RAW":[91],"264.7":[92],"mouse":[93,141],"PAI-2":[97,170],"human":[102,172],"macrophages.":[103,173],"The":[104],"antitumor":[105,240],"these":[108,129],"were":[110,131],"tested":[111,184],"vivo":[113],"transplanted":[115],"Dunning":[116],"R-3327":[117],"MAT-Lu":[118,179],"rat":[119],"prostate":[120,277],"cancers;":[121],"TAM":[122,187],"numbers":[123,188],"vessel":[126,210,225],"densities":[127],"cancers":[130],"determined":[132],"immunocytochemistry.":[136],"RESULTS:":[137],"selectively":[139],"inhibited":[140,155],"secretion":[143],"but":[146,162],"not":[147,163],"GM-CSF;":[149],"however,":[150],"both":[159],"cytokines.":[160],"Linomide,":[161],"thalidomide":[164],"increased":[167],"When":[174],"administered":[175],"to":[176,272],"rats":[177],"bearing":[178],"tumors,":[180],"each":[181],"reduced":[186,207],"(Linomide,":[189],"46%;":[191],"94%;":[194],"71%;":[197],"genistein,":[199],"96%).":[201],"However,":[202],"all":[203],"density":[211,226],"growth,":[214],"with":[215],"being":[217],"most":[219],"effective":[220,275],"(44%":[221],"reduction":[222],"69%":[228],"inhibition":[229],"growth).":[232],"None":[233],"other":[236],"potentiated":[238],"Linomide's":[239],"effect.":[241],"CONCLUSIONS:":[242],"is":[244],"unique":[245],"among":[246],"it":[253],"inhibits":[254],"stimulatory":[256],"TAMs":[259],"without":[263],"eliminating":[264],"their":[265],"effects,":[267],"may":[269],"thus":[270],"prove":[271],"be":[273],"more":[274],"against":[276],"cancer.":[278]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2129404229","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
